4th Mar 2008 16:27
GlaxoSmithKline Capital PLC04 March 2008 Publication of Prospectus The following Securities Note has been approved by the UK Listing Authority andis available for viewing: Securities Note dated 4 March 2008 relating to theissue by GlaxoSmithKline Capital plc of £700,000,000 6.375 per cent. Fixed RateNotes due 9 March 2039 issued under the £10,000,000,000 EMTN programme andguaranteed by GlaxoSmithKline plc. To view the full document, please paste the following URL into the address bar of your browser. http://www.rns-pdf.londonstockexchange.com/rns/3620p_-2008-3-4.pdf For further information, please contact: GlaxoSmithKline plc980 Great West RoadBrentfordMiddlesexTW8 9GS Enquiries: UK Media enquiries: Philip Thomson (020) 8047 5502 European Analyst/Investor enquiries: David Mawdsley (020) 8047 5564 Sally Ferguson (020) 8047 5543 DISCLAIMER - INTENDED ADDRESSEES Please note that the information contained in the Securities Note, when readtogether with the Issuer's Registration Document, (the "Prospectus") may beaddressed to and/or targeted at persons who are residents of particularcountries (specified in the Prospectus) only and is not intended for use andshould not be relied upon by any person outside these countries and/or to whomthe offer contained in the Prospectus is not addressed. Prior to relying on theinformation contained in the Prospectus you must ascertain from the Prospectuswhether or not you are part of the intended addressees of the informationcontained therein. Your right to access this service is conditional upon complying with the above requirement. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline